Meeder Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.18K | Buy |
+30
| New | +$3.18K | ﹤0.01% | 770 |
|
|
2022
Q4 | – | Sell |
-125
| Closed | -$17K | – | 1401 |
|
|
2022
Q3 | $17K | Buy |
125
+76
| +155% | +$10.3K | ﹤0.01% | 1154 |
|
|
2022
Q2 | $8K | Sell |
49
-204
| -81% | -$33.3K | ﹤0.01% | 1455 |
|
|
2022
Q1 | $39K | Sell |
253
-22
| -8% | -$3.39K | ﹤0.01% | 1048 |
|
|
2021
Q4 | $35K | Sell |
275
-3
| -1% | -$382 | ﹤0.01% | 552 |
|
|
2021
Q3 | $36K | Sell |
278
-968
| -78% | -$125K | ﹤0.01% | 1198 |
|
|
2021
Q2 | $221K | Sell |
1,246
-327
| -21% | -$58K | 0.01% | 702 |
|
|
2021
Q1 | $259K | Buy |
1,573
+1,529
| +3,475% | +$252K | 0.01% | 673 |
|
|
2020
Q4 | $7K | Sell |
44
-164
| -79% | -$26.1K | ﹤0.01% | 1104 |
|
|
2020
Q3 | $29K | Sell |
208
-1,878
| -90% | -$262K | ﹤0.01% | 1070 |
|
|
2020
Q2 | $230K | Sell |
2,086
-453
| -18% | -$49.9K | 0.02% | 565 |
|
|
2020
Q1 | $253K | Buy |
2,539
+32
| +1% | +$3.19K | 0.02% | 506 |
|
|
2019
Q4 | $375K | Buy |
2,507
+34
| +1% | +$5.09K | 0.02% | 448 |
|
|
2019
Q3 | $317K | Sell |
2,473
-30
| -1% | -$3.85K | 0.02% | 495 |
|
|
2019
Q2 | $358K | Sell |
2,503
-94
| -4% | -$13.4K | 0.03% | 464 |
|
|
2019
Q1 | $372K | Hold |
2,597
| – | – | 0.03% | 426 |
|
|
2018
Q4 | $321K | Sell |
2,597
-334
| -11% | -$41.3K | 0.03% | 403 |
|
|
2018
Q3 | $494K | Buy |
+2,931
| New | +$494K | 0.04% | 357 |
|